Clinical Trial Update: Risk Clinical Stratification of Sickle Cell Disease in Nigeria, Assessment of Efficacy/Safety of Hydroxyurea Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial assessing risk stratification and the efficacy/safety of hydroxyurea treatment in sickle cell disease in Nigeria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Loyola University | Conditions: Sickle Cell Disease, Sickle Cell Anemia | Phase 4 | Status: COMPLETED